R. Ieki et al. / Journal of Organometallic Chemistry 751 (2014) 471e474
473
Table 2
Reductive aldol reaction of enone 1 with functionalized ketones 2.
a
Scheme 5. Plausible mechanism through chelated cyclic transition state.
Entry
1
Ketone 2
Product 3
Yield% (dr)
64 (99:1)
2
3
0), 149 (100), 105 (PhCO, 18). HRMS calcd for C18
H
19BrO
2
:
þ
46.0568, found: m/z 347.0650 (CI, M þ 1, þ0.3 mmu). Major
1
isomer (2R*,3R*) H NMR (CDCl
Ph(o)), 7.64e7.60 (m,1H,1-Ph(p)), 7.57e7.54 (m, 2H, 3-Ph(o)), 7.50e
.48 (m, 2H, 1-Ph(m)), 7.39e7.35 (m, 2H, 3-Ph(m)), 7.30e7.28 (m,
H, 3-Ph(p)), 4.81 (s, 1H, OH), 4.13 (dd, J ¼ 3.6 and 10.1 Hz, 1H,
CHEt), 3.76 (d, J ¼ 10.6 Hz, 1H, CH Br), 3.56 (d, J ¼ 10.6 Hz, 1H,
CH Me), 1.54
Br), 1.82 (qdd, J ¼ 7.4 and 10.1 and 13.7 Hz, 1H, CH
qdd, J ¼ 3.6 and 7.7 and 13.7 Hz, 1H, CH Me), 0.68 (t, J ¼ 7.4 and
, 100 MHz) 207.2, 142.0, 137.9,
34.0, 128.8, 128.5, 128.1, 127.4, 125.5, 77.5, 52.7, 42.3, 23.2, 12.4.
3
, 400 MHz) d 8.03e8.00 (m, 2H, 1-
7
1
2
2
71 (>99:1)
2
2
(
2
13
7.7 Hz, 3H, Me). C NMR (CDCl
3
d
1
3
4
60 (85:15)
1
3
Minor isomer (2S*,3R*) H NMR (CDCl , 400 MHz) d 7.85 (d,
J ¼ 7.4 Hz, 2H, 1-Ph(o)), 7.55e7.52 (m, 1H, 1-Ph(p)), 7.46e7.39 (m,
4
1
H,1-Ph(m) and 3-Ph(o)), 7.26e7.22 (m, 2H, 3-Ph(m)), 7.18e7.14 (m,
H, 3-Ph(p)), 4.39 (s, 1H, OH), 4.17 (dd, J ¼ 3.8 and 10.6 Hz, 1H,
61 (>99:1)
CHEt), 3.97 (d, J ¼ 10.6 Hz, 1H, CH Br), 3.91 (d, J ¼ 10.6 Hz, 1H,
2
CH
2
Br), 2.00 (qdd, J ¼ 7.2 and 10.6 and 13.7 Hz, 1H, CH
Me), 0.84 (dd, J ¼ 7.2 and
, 100 MHz) 205.7, 143.5, 138.4,
33.4, 128.5, 128.3, 128.0, 127.4, 125.8, 77.3, 53.5, 40.4, 21.5, 12.6.
2
Me), 1.85
(
7
qdd, J ¼ 3.8 and 7.7 and 13.7 Hz, 1H, CH
2
13
.7 Hz, 3H, Me). C NMR (CDCl
3
d
5
72 (96:4)
1
a
4.1.4. (2R*,3R*)-3-Benzoyl-2-hydroxy-2-phenyl-pentanoic acid
methyl ester (3d)
Conditions: Br
2
InOMe (0.1 mmol), MePhSiH
2
(1.1 mmol), MeOH (1.0 mmol), 1
(
1 mmol), 2 (1 mmol), MeCN (1 mL).
The NMR data well agree with the reported data in Ref. [2i].
ꢀ
ꢂ1
ꢂ1
þ
White solid. Mp 73 C. IR (KBr) 3409 cm (OH), 1720 cm (C]
C
19
H
21BrO
2
: 361.2728, found: m/z 361.0799 (CI, M þ 1, ꢂ0.4 mmu).
ꢂ1
þ
1
O), 1650 cm (C]O). MS (CI, 200 eV) m/z 313 (M þ 1, 100), 165
58), 149 (84). HRMS calcd for C19 : 312.1362, found: m/z
, 400 MHz) 8.07e
.05 (m, 2H, COPh(o)), 7.71e7.69 (m, 2H, 2-Ph(o)), 7.64e7.59 (m, 1H,
Major isomer (2S*,3S*,4R*) H NMR (CDCl
3
, 400 MHz) d 7.99 (d,
(
3
8
20 4
H O
J ¼ 7.2 Hz, 2H, 1-Ph(o)), 7.60 (d, J ¼ 7.2 Hz, 1H, 1-Ph(p)), 7.48 (t,
þ
1
13.1444 (CI, M þ 1, þ0.4 mmu). H NMR (CDCl
3
d
J ¼ 7.2 Hz, 2H, 1-Ph(m)), 7.36e7.21 (m, 5H, 5-Ph), 4.46 (d, J ¼ 9.4 Hz,
1
H, OH), 4.17 (ddd, J ¼ 2.9, 7.0 and 10.4 Hz, 1H, CHEt), 4.03 (ddd,
COPh(p)), 7.53e7.39 (m, 4H, 2-Ph(m) and COPh(m)), 7.35e7.31 (m,
J ¼ 2.9, 8.9 and 12.3 Hz, 1H, CHBr), 3.96 (ddd, J ¼ 2.9, 9.4 and
Ph), 3.08
Me), 1.00
201.1, 138.1,
36.8, 134.0, 129.6, 128.8, 128.7, 128.2, 126.6, 75.8, 59.1, 47.4, 40.9,
1
3
H, 2-Ph(p)), 5.36 (s, 1H, OH), 4.31 (dd, J ¼ 4.8 and 8.2 Hz, 1H, CHEt),
.55 (s, 3H, OMe), 1.66e1.50 (m, 2H, CH
Me), 0.61 (t, J ¼ 7.7 Hz, 3H,
208.3, 174.8, 139.0, 137.2, 133.7,
1
(
(
1
2
2.3 Hz, 1H, CHOH), 3.73 (dd, J ¼ 2.9 and 14.7 Hz, 1H, CH
dd, J ¼ 8.9 and 14.7 Hz, 1H, CH Ph), 1.90e1.83 (m, 2H, CH
t, J ¼ 7.5 Hz, 3H, Me). C NMR (CDCl , 100 MHz)
2
2
2
2
13
13
Me). C NMR (CDCl
3
, 100 MHz)
d
3
d
1
28.6, 128.5, 128.3, 127.9, 125.0, 81.0, 53.5, 52.7, 21.0, 12.5.
1
4.4, 12.2. Minor isomer (2S*,3R*,4R*) H NMR (CDCl
3
, 400 MHz)
0
.1.5. (2R*,3R*)-3-Benzoyl-2-(4 -bromo-phenyl)-2-hydroxy-
4
d
7.98 (d, J ¼ 7.2 Hz, 2H, 1-Ph(o)), 7.65e7.21 (m, 8H, 1-Ph(p), 1-
pentanoic acid methyl ester (3e)
Ph(m), 5-Ph(o), 5-Ph(m) and 5-Ph(p)), 4.43 (ddd, J ¼ 1.7, 7.5 and
.7 Hz, 1H, CHBr), 4.00 (brs, 1H, OH), 3.93 (dd, J ¼ 1.7 and 8.0 Hz, 1H,
CHOH), 3.84 (ddd, J ¼ 4.8, 8.0 and 8.0 Hz, 1H, CHEt), 3.38 (dd, J ¼ 7.5
and 14.2 Hz, 1H, CH Ph),
Ph), 3.26 (dd, J ¼ 7.7 and 14.3 Hz, 1H, CH
.77e1.51 (m, 2H, CH
Me), 0.75 (t, J ¼ 7.7 Hz, 3H, Me). C NMR
CDCl , 100 MHz) 203.3, 137.9, 133.5, 129.1, 128.7, 128.5, 128.4,
The NMR data well agree with the reported data in Ref. [2i].
White solid. Mp 112 C, recrystallization from hexane/Et
KBr) 3444 cm (OH),1723 cm (C]O),1659 cm (C]O). MS (CI,
7
ꢀ
2
O. IR
ꢂ1
ꢂ1
ꢂ1
(
2
2
þ
13
200 eV) m/z 391 (M þ 1, 20), 243 (30), 149 (84). HRMS calcd for
1
(
2
þ
C
19
H
19BrO
H NMR (CDCl
.47 (m, 7H, COPh(m) and COPh(p) and 2-Ph(o) and 2-Ph(m)), 5.37
s, 1H, OH), 4.25 (dd, J ¼ 4.8 and 8.2 Hz, 1H, CHEt), 3.57 (s, 3H, OMe),
.67e1.58 (m, 1H, CH Me), 1.54e1.44 (m, 1H, CH Me), 0.63 (t,
, 100 MHz) 208.0, 174.5, 138.2,
4
: 390.0467, found: m/z 391.0543 (CI, M þ 1, ꢂ0.2 mmu).
3
d
1
3
, 400 MHz)
d
8.04 (d, J ¼ 8.6 Hz, 2H, COPh(o)), 7.66e
126.9, 125.2, 72.5, 63.4, 52.7, 42.8, 23.3, 11.0.
7
(
1
4
1
.1.3. (2R*,3R*)-4-Bromo-2-ethyl-3-hydroxy-1, 3-diphenyl-butan-
-one (3c)
The NMR data well agree with the reported data in Ref. [2i].
2
2
13
J ¼ 7.4 Hz, 3H, Me). C NMR (CDCl
3
d
ꢂ1
ꢂ1
137.2, 133.9, 131.6, 128.7, 128.6, 127.0, 122.2, 80.8, 53.4, 53.0, 21.0,
12.6.
Colorless liquid. IR (neat) 3433 cm (OH), 1655 cm (C]O).
MS (CI, 200 eV) m/z 347 (M þ 1, 4), 199 (Mþ ꢂ PhCOCH
þ
2
2 3
CH CH ,
Scheme 4. Dehalogenation of 3c.
Scheme 6. Control of diastereoselectivity of three contiguous stereogenic centers.